// App-Quantinova.ai

PB0082 : Biomarkers in COVID-19: Association with disease severity and outcomes

Researchers

Presenter

  • M. Peralta

Principal Investigators

  • V. Muczynski

  • P. Lane

  • A. Riddell

  • B. Agarwal

  • K. Gomez

  • A. Drebes

  • J. McVey

  • D. Martin

  • A. Davenport

  • A. Brachat

  • T. Sood

  • L. Lanning

  • P. Chowdary

Medical Centers

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

  • Research Department of Haematology, University College London (UCL) – Cancer Institute, London, United-Kingdom, London, England, United Kingdom

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

  • Department of Intensive care and Anaesthesia, Royal Free London NHS Foundation Trust, London, UK, London, England, United Kingdom

  • Department of Intensive care and Anaesthesia, Royal Free London NHS Foundation Trust, London, UK, London, England, United Kingdom

  • Cancer Institute, University College London, London, UK, London, England, United Kingdom

  • University of Surrey, Guildford, United Kingdom

  • Royal Free London NHS Foundation Trust, London, UK, London, England, United Kingdom

  • Cancer Institute, University College London, London, UK, London, England, United Kingdom

  • Biozentrum, University of Basel, Basel, Basel-Landschaft, Switzerland

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved